½ÃÀ庸°í¼­
»óǰÄÚµå
1594666

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°, ¾ç½Ä, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Ophthalmic Ultrasound Imaging System Market by Product (A- Scan, B- Scan, Combined Scan), Modality (Portable, Standalone), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 43¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 47¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 7.87% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 74¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå¿¡´Â ºñħ½ÀÀû ÃÊÀ½ÆÄ ½Ã¼úÀ» ÅëÇØ ¾È°ú ÁúȯÀ» Áø´ÜÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â µ¥ »ç¿ëµÇ´Â Àåºñ¿Í ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº Àü¾ÈºÎ, ÈľȺÎ, ¸Á¸· ¹Ú¸®, Á¾¾ç ¹× ±âŸ º´º¯À» Æ÷ÇÔÇÑ ¾È±¸ ±¸Á¶ÀÇ ½Ã°¢È­¿¡ Àû¿ëµÇ´Â °ÍÀ¸·Î Á¤ÀǵǸç, ¾È±¸ °ü·Ã ÁúȯÀÇ Áõ°¡¿Í ½Ã·Â Àå¾Ö¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ±× Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ ¿ëµµ´Â º´¿ø, ¾È°ú Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿¡ À̸£±â±îÁö ¾È°ú ÀÇ»ç ¹× ¾È°ú ¿Ü°úÀǻ縦 Æ÷ÇÔÇÑ ±¤¹üÀ§ÇÑ ÃÖÁ¾»ç¿ëÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â AI¿ÍÀÇ ÅëÇÕÀ» ÅëÇÑ ¿µ»ó Á¤È®µµ Çâ»ó°ú °°Àº ±â¼ú ¹ßÀü, ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¾È°ú ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÈÞ´ë¿ë ±â±âÀÇ ¹ßÀü°ú ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë, ƯÈ÷ Àú°³¹ß Áö¿ª¿¡¼­ÀÇ ¿ø°ÝÀÇ·á ¼­ºñ½º È®´ë´Â ÀÇ·á ¼­ºñ½º¸¦ Á¦´ë·Î ¹ÞÁö ¸øÇÏ´Â »ç¶÷µé¿¡°Ô È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ÃֽŠÀáÀçÀû ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±ÇÀå»çÇ×À¸·Î´Â ¼ÒÇüÈ­ ¹× ÈÞ´ë °¡´ÉÇÑ Áø´Ü ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ Ȱ¿ëÇϰí, Á¢±Ù¼º°ú ¼º´ÉÀ» Çâ»ó½ÃŰ´Â ±â¼ú °³¹ßÀ» À§ÇÑ Àü·«Àû Çù·Â °ü°è¸¦ È®´ëÇÏ´Â °ÍÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï ½ÃÀåÀÇ ³ôÀº ±â±â ºñ¿ë, ºÒÃæºÐÇÑ ÀÇ·áºñ »óȯ Á¤Ã¥, ¼÷·ÃµÈ Àü¹® Àη ºÎÁ· µîÀÇ ¹®Á¦°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ°ú Áö¿ªº°·Î »óÀÌÇÑ ±ÔÁ¤ Áؼö ±âÁذú °°Àº ÀáÀçÀû Á¦¾àÀ¸·Î ÀÎÇØ Á¦Ç° °³¹ß ¹× ½ÂÀÎ ÀýÂ÷°¡ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½Å¿¡´Â Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í ÀÎÀû ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ AI¸¦ Ȱ¿ëÇÑ ¿µ»ó ºÐ¼®ÀÇ ¹ßÀü°ú ¿ø°ÝÁö³ª ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­ º¸±ÞÀ» ÃËÁøÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÎ ÈÞ´ë¿ë ¼Ö·ç¼Ç °³¹ßÀÌ Æ÷Ç﵃ ¼ö ÀÖ½À´Ï´Ù. ±âº»ÀûÀ¸·Î ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü ½ÃÀåÀº Á¤¹ÐÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ µû¶ó ÁøÈ­Çϰí ÀÖÁö¸¸, Áö¼ÓÀûÀÎ ¼ºÀå°ú º¸±ÞÀ» À§Çؼ­´Â ±ÔÁ¦ À庮°ú °æÁ¦Àû °ÝÂ÷¸¦ ±Øº¹ÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 43¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 47¾ï ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 74¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 7.87%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¾È°ú Áúȯ ¹× ±âŸ ¿Ü»ó¼º ¾È±¸ ¿Ü»ó À¯º´·ü Áõ°¡
    • °³¹ßµµ»ó±¹ÀÇ ¾È°ú Àü¹® Ŭ¸®´Ð Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ÷´Ü ±â¼ú °ü·Ã °¡°Ý ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ
  • ½ÃÀå ±âȸ
    • ¾È±¸ ³» ÃøÁ¤ ¹× Àü¾ÈºÎ °Ë»ç¿¡¼­ »õ·Î¿î ÷´Ü ¿µ»ó ½Ã½ºÅÛ °³¹ß
    • Á¤ºÎÀÇ °øÁߺ¸°Ç ÀÎ½Ä Á¦°í ÇÁ·Î±×·¥ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ´Ù¸¥ Áø´Ü µµ±¸ äÅà ¹× °³¹ß

Porter's Five Forces : ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀü°úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • A ½ºÄµ
  • B ½ºÄµ
  • º¹ÇÕ ½ºÄµ
  • ÆÄŰ¹ÌÅÍ
  • ÃÊÀ½ÆÄ »ýü Çö¹Ì°æ °Ë»ç

Á¦7Àå ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ÈÞ´ë¿ë
  • µ¶¸³Çü

Á¦8Àå ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ¾È°ú Ŭ¸®´Ð
  • ¾È°ú º´¿ø
  • ¾È°ú Á¶»ç±â°ü

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Alpinion Medical Deutschland GmbH
  • Appasamy Associates
  • Carl Zeiss Meditec AG
  • DGH Technology, Inc
  • Ellex Medical
  • Halma PLC
  • Keeler USA
  • Koninklijke Philips N.V.
  • Micro Medical Devices(MMD), Inc.
  • NIDEK Co., Ltd.
  • Optos PLC
  • Quantel Medical
  • Sonogage, Inc.
  • Sonomed, Inc.
  • UNIVERSAL SOLUTIONS, INC.
ksm 24.11.28

The Ophthalmic Ultrasound Imaging System Market was valued at USD 4.36 billion in 2023, expected to reach USD 4.70 billion in 2024, and is projected to grow at a CAGR of 7.87%, to USD 7.41 billion by 2030.

The ophthalmic ultrasound imaging system market encompasses devices and technologies utilized for diagnosing and monitoring ocular conditions through non-invasive ultrasound procedures. Defined by its application in visualizing the eye structure, including the anterior and posterior segments, retinal detachments, tumors, and other pathologies, this market has witnessed a growing necessity due to increased incidences of eye-related disorders and expanding elderly population vulnerable to vision ailments. The application of these systems extends to hospitals, ophthalmic clinics, and ambulatory surgical centers, catering to a wide range of end-users including ophthalmologists and ocular surgeons. Key growth influencers include technological advancements like integration with AI for enhanced imaging accuracy, increased investment in healthcare infrastructure, and growing awareness about early diagnosis and treatment of eye conditions. Additionally, latest potential opportunities arise in the development of portable devices and expanding telemedicine services, especially in underdeveloped regions, providing efficient solutions to underserved populations. Recommendations include capitalizing on growing demand for miniaturized and portable diagnostic devices, and expanding strategic collaborations for technological development to improve accessibility and performance. However, market growth is hindered by challenges such as high costs of equipment, insufficient healthcare reimbursement policies, and lack of skilled professionals in emerging markets. Moreover, potential limitations include stringent regulatory environments and varying compliance standards across regions, which may delay product development and approval processes. Innovating within this space could involve advancements in AI-driven imaging analytics to improve diagnostic precision and reduce human error, as well as development of cost-effective, portable solutions that facilitate wider reach in remote or resource-limited settings. Essentially, the ophthalmic ultrasound imaging market is evolving, driven by rising need for precise diagnostic tools, but navigating regulatory barriers and economic disparities remains essential for sustained growth and penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 4.36 billion
Estimated Year [2024] USD 4.70 billion
Forecast Year [2030] USD 7.41 billion
CAGR (%) 7.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Ultrasound Imaging System Market

The Ophthalmic Ultrasound Imaging System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of ophthalmic diseases and other traumatic eye injuries
    • Increasing number of specialty eye care clinics in developing regions
  • Market Restraints
    • Price associated with hi-tech ophthalmic ultrasound imaging system
  • Market Opportunities
    • Development of new advanced imaging systems in intraocular measurement and anterior segment examination
    • Rise in public health awareness programs by government
  • Market Challenges
    • Adoption and development of other diagnostic tools

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Ultrasound Imaging System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Ultrasound Imaging System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Ultrasound Imaging System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Ultrasound Imaging System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Ultrasound Imaging System Market

A detailed market share analysis in the Ophthalmic Ultrasound Imaging System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Ultrasound Imaging System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Ultrasound Imaging System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Ultrasound Imaging System Market

A strategic analysis of the Ophthalmic Ultrasound Imaging System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Ultrasound Imaging System Market, highlighting leading vendors and their innovative profiles. These include Alpinion Medical Deutschland GmbH, Appasamy Associates, Carl Zeiss Meditec AG, DGH Technology, Inc, Ellex Medical, Halma PLC, Keeler USA, Koninklijke Philips N.V., Micro Medical Devices (MMD), Inc., NIDEK Co., Ltd., Optos PLC, Quantel Medical, Sonogage, Inc., Sonomed, Inc., and UNIVERSAL SOLUTIONS, INC..

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Ultrasound Imaging System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across A- Scan, B- Scan, Combined Scan, Pachymeter, and Ultrasound Bio-microscopy.
  • Based on Modality, market is studied across Portable and Standalone.
  • Based on End User, market is studied across Ambulatory Surgical Centre, Eye Clinics, Eye Hospitals, and Eye Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of ophthalmic diseases and other traumatic eye injuries
      • 5.1.1.2. Increasing number of specialty eye care clinics in developing regions
    • 5.1.2. Restraints
      • 5.1.2.1. Price associated with hi-tech ophthalmic ultrasound imaging system
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new advanced imaging systems in intraocular measurement and anterior segment examination
      • 5.1.3.2. Rise in public health awareness programs by government
    • 5.1.4. Challenges
      • 5.1.4.1. Adoption and development of other diagnostic tools
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmic Ultrasound Imaging System Market, by Product

  • 6.1. Introduction
  • 6.2. A- Scan
  • 6.3. B- Scan
  • 6.4. Combined Scan
  • 6.5. Pachymeter
  • 6.6. Ultrasound Bio-microscopy

7. Ophthalmic Ultrasound Imaging System Market, by Modality

  • 7.1. Introduction
  • 7.2. Portable
  • 7.3. Standalone

8. Ophthalmic Ultrasound Imaging System Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centre
  • 8.3. Eye Clinics
  • 8.4. Eye Hospitals
  • 8.5. Eye Research Institutes

9. Americas Ophthalmic Ultrasound Imaging System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmic Ultrasound Imaging System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmic Ultrasound Imaging System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alpinion Medical Deutschland GmbH
  • 2. Appasamy Associates
  • 3. Carl Zeiss Meditec AG
  • 4. DGH Technology, Inc
  • 5. Ellex Medical
  • 6. Halma PLC
  • 7. Keeler USA
  • 8. Koninklijke Philips N.V.
  • 9. Micro Medical Devices (MMD), Inc.
  • 10. NIDEK Co., Ltd.
  • 11. Optos PLC
  • 12. Quantel Medical
  • 13. Sonogage, Inc.
  • 14. Sonomed, Inc.
  • 15. UNIVERSAL SOLUTIONS, INC.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦